• HOME>
  • Investor Relations>
  • IR News>
  • Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions

IR News

Mar. 02, 2021Print(PDF/131KB)Corporate

Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes in the Positions Assumed by Executive Officers and Other Key Positions

Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following organizational realignment and changes in the positions assumed by Executive Officers and other key positions, effective April 1, 2021:

I. Organizational Realignment (effective April 1, 2021)

Sales & Marketing (Division)

1. Kita-Kanto-Koshinetsu Branch is created by integrating Kita-Kanto Branch and Koshinetsu Branch.
2. Saitama-Chiba Branch is created by integrating Chiba Branch and Saitama Branch.

II. Changes in the Positions Assumed by Executive Officers (effective April 1, 2021)

Position as of April 1, 2021 Current position Name
Representative Director,
Executive Vice President
Chief Scientific Officer
Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant
Member, Board of Directors,
Senior Executive Officer
Chief Scientific Officer
Regenerative & Cellular Medicine Office; Regenerative & Cellular Medicine Kobe Center; Regenerative & Cellular Medicine Manufacturing Plant; Drug Research Division
Senior Executive Research Director, Drug Research Division
Toru Kimura
Senior Executive Officer
Drug Research Division
Senior Executive Research Director, Drug Research Division
Executive Officer
Executive Research Director, Drug Research Division
Senior Director, Research Planning & Coordination
Hideyuki Harada
Executive Officer
Deputy Executive Director, Sales & Marketing Division
Executive Officer
Deputy Executive Director, Sales & Marketing Division
Senior Director, Sales & Marketing Management
Takuya Taguchi
Executive Officer
Executive Director, Technology Research & Development Division
Executive Director, Technology Research & Development Division Kenji Ueno
"Changes of Representative Directors and Executive Officers effective on April 1, 2021" was disclosed on February 26, 2021.

III. Changes in Personnel (effective April 1, 2021)

Corporate Departments

Position as of April 1, 2021 Current position Name
Senior Director, International Business Management Managing Director, Sumitomo Pharmaceuticals (Thailand) Co., Ltd. Tatsuya Ito
Senior Medical Officer, Ophthalmology Officer, Ophthalmology, Regenerative & Cellular Medicine Office Koichiro Manabe
Chair and CEO, Sumitomo Dainippon Pharma America, Inc. Director, Accounting Group, Finance & Accounting Koji Ishida

Drug Research (Division)

Position as of April 1, 2021 Current position Name
Senior Director, Research Planning & Coordination Fellow, Synapse Pathology-based Drug Discovery, Pharmacology Research Unit Masakuni Horiguchi
Senior Director, Pharmacology Research Unit Director, Pharmacology Group Ⅱ, Pharmacology Research Unit Mitsugu Yamanaka

Technology Research & Development (Division)

Position as of April 1, 2021 Current position Name
Senior Director, Formulation Research & Development Laboratories Director, Formulation Research Group Ⅲ, Formulation Research & Development Laboratories Makiko Yanagida

Sales & Marketing (Division)

Position as of April 1, 2021 Current position Name
Senior Director, Sales & Marketing Management Senior Director, Chugoku Branch Yasutoshi Araki
Senior Director, Kita-Kanto-Koshinetsu Branch Senior Director, Kita-Kanto Branch Takafumi Shimizu
Senior Director, Saitama-Chiba Branch Senior Director, Saitama Branch Yasunori Shiroyama
Senior Director, Chugoku Branch Senior Director, Koshinetsu Branch Yasushi Kimura

Manufacturing (Division)

Position as of April 1, 2021 Current position Name
Senior Director, Manufacturing Management Senior Director, Formulation Research & Development Laboratories Kimihiro Mizuno
Senior Director, Manufacturing Technology Deputy Senior Director, Manufacturing Department I, Suzuka Plant Hideo Kurita
Senior Director, Suzuka Plant Senior Director, Manufacturing Technology Mitsuhito Kondo
Deputy Senior Director, Manufacturing Department I, Suzuka Plant Deputy Senior Director, Manufacturing Department II, Suzuka Plant Toru Fukushima
Deputy Senior Director, Manufacturing Department II, Suzuka Plant Director, Narcotics Manufacturing Section, Manufacturing Department II, Suzuka Plant Keishi Shigeyama